Control of nausea and vomiting by Navoban (tropisetron) in 131 children receiving cytotoxic chemotherapy.

Abstract

One hundred and thirty-one children with a median age of 5 years were administered Navoban (tropisetron), a selective antagonist of the serotonin receptor (5-HT3), dosed once daily at 0.2 mg/kg (with a maximum of 5 mg daily) in a study aimed at evaluating the prevention of nausea and vomiting induced by anti-cancer chemotherapy. The most common malignancy… (More)

Topics

Cite this paper

@article{Benoit1995ControlON, title={Control of nausea and vomiting by Navoban (tropisetron) in 131 children receiving cytotoxic chemotherapy.}, author={Yves Benoit and Frank Hulstaert and Christiane Vermylen and Eric Sariban and Claire Hoyoux and Anne M Uyttebroeck and Jeroen J. T. Otten and Genevi{\'e}ve Laureys and I De Kerpel and D Nortier}, journal={Anti-cancer drugs}, year={1995}, volume={6 Suppl 1}, pages={9-14} }